BIOSPHERICS INC
8-K, 1999-03-26
ENGINEERING, ACCOUNTING, RESEARCH, MANAGEMENT
Previous: BIG V SUPERMARKETS INC, 10-K405, 1999-03-26
Next: BRADLEY REAL ESTATE INC, DEF 14A, 1999-03-26



<PAGE>


- --------------------------------------------------------------------------------


                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K
                                 CURRENT REPORT

     Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934

                          DATE OF REPORT: MARCH 26, 1999
                        --------------------------------
                        (Date of earliest event reported)


                            BIOSPHERICS INCORPORATED
- --------------------------------------------------------------------------------
             (Exact name of registrant as specified in its charter)


         Delaware                      0-5576                 52-0849320
- ------------------------------ ---------------------     ---------------------
(State or other jurisdiction   (Commission file number)   (I.R.S. Employer
      of incorporation)                                   Identification No.)

12051 Indian Creek Court, Beltsville, Maryland                   20705
- --------------------------------------------------------------------------------
  (Address of Principal Executive Offices)                     (Zip Code)


       Registrant's Telephone Number, including area code: (301) 419-3900


                                 Not Applicable
- --------------------------------------------------------------------------------
          (Former name or former address, if changed since last report)






ITEM 5.           OTHER EVENTS

         Biospherics Incorporated (the "Company") is filing herewith, as Exhibit
99, a cautionary statement for purposes of the "Safe Harbor For Forward-Looking
Statements" provision of the Private Securities Litigation Reform Act of 1995.


<PAGE>



ITEM 7.           FINANCIAL STATEMENTS AND EXHIBITS.

Exhibit No.       Description
- -----------       -----------
99                Cautionary Statement






                                   SIGNATURES


         Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

Biospherics Incorporated


By: /s/  Gilbert V. Levin  
     ---------------------------------
     Gilbert V. Levin
     Chairman of the Board, President,
     and Treasurer


March 26, 1999
- --------------
Date




                                       2


<PAGE>




                                                                      EXHIBIT 99

                              CAUTIONARY STATEMENT

         Biospherics Incorporated ("Biospherics") and its representatives from
time to time participate in speeches and calls with market analysts, conferences
with investors and potential investors of Biospherics' securities, and other
meetings and conferences. Some of the information presented in such speeches,
calls, meetings and conferences may be forward-looking statements based on
current expectations, estimates and projections about Biospherics and the
industries in which it operates. These statements are not guarantees of future
performance and involve risks and uncertainties that could result in actual
results differing materially from expected results.

         It is not reasonably possible to itemize all of the many factors and
specific events that could affect Biospherics and its businesses. Some factors
that could cause actual results to differ materially from any or all such
forward-looking statements are:

         The timing of and/or effectiveness of MD Foods Ingredients anba of
Denmark ("MD Foods") in bringing Biospherics' low caloric sugar, D-tagatose,
to market as a sweetener; accuracy of the estimates of the various markets for
D-tagatose supplied Biospherics by MD Foods; the success of MD Foods' efforts to
establish D-tagatose as a substance Generally Recognized as Safe (GRAS); the
timing of and/or effectiveness of Biospherics' efforts to develop D-tagatose as
an adjunct treatment for type 2 diabetes and to otherwise commercialize
D-tagatose; the effectiveness of Biospherics in its entrance into the demand
management business; the ability of Biospherics to maintain and extend its
position in information technology; rapid technological developments and changes
and Biospherics' ability to continue to introduce competitive new products and
services on a timely, cost-effective basis; continued availability of financing
in the amounts, at the times and on terms required to support Biospherics
business endeavors; Year 2000 readiness; wage rates of employee peer groups of
competitors; industry compensation levels; actions of the U.S., foreign and
local governments; foreign currency exchange rate fluctuations; the stability of
the U.S. economy; the price of Biospherics common stock; inflation; increased
competition in all lines of business and the economic environment in general.




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission